Literature DB >> 24567369

The myc 3' wnt-responsive element suppresses colonic tumorigenesis.

Wesley M Konsavage1, Gregory S Yochum.   

Abstract

Mutations in components of the Wnt/β-catenin signaling pathway are commonly found in colorectal cancers, and these mutations cause aberrant expression of genes controlled by Wnt-responsive DNA elements (WREs). While the c-Myc proto-oncogene (Myc) is required for intestinal phenotypes associated with pathogenic Wnt/β-catenin signaling in vivo, the WREs that control Myc expression in this setting have yet to be fully described. Previously, we demonstrated that the Myc 3' WRE was required for intestinal homeostasis and intestinal repair in response to damage. Here, we tested the role of the Myc 3' WRE in intestinal tumorigenesis using two independent mouse models. In comparison to Apc(Min/+) mice, Apc(Min/+) Myc 3' WRE(-/-) mice contained 25% fewer tumors in the small intestine. Deletion of the Myc 3' WRE(-/-) in the Apc(Min/+) background resulted in 4-fold more colonic tumors. In a model of colitis-associated colorectal cancer, the Myc 3' WRE suppressed colonic tumorigenesis, most notably within the cecum. Using chromatin immunoprecipitation and transcript analysis of purified colonic crypts, we found that the Myc 3' WRE is required for the transcriptional regulation of Myc expression in vivo. These results emphasize the critical role of the Myc 3' WRE in maintaining homeostatic Myc expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24567369      PMCID: PMC3993608          DOI: 10.1128/MCB.00969-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

Review 1.  Mouse models of gastrointestinal tumors.

Authors:  Makoto Mark Taketo
Journal:  Cancer Sci       Date:  2006-05       Impact factor: 6.716

2.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

3.  Homeosis and intestinal tumours in Cdx2 mutant mice.

Authors:  K Chawengsaksophak; R James; V E Hammond; F Köntgen; F Beck
Journal:  Nature       Date:  1997-03-06       Impact factor: 49.962

Review 4.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

5.  Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse.

Authors:  Natalia A Ignatenko; Hana Holubec; David G Besselsen; Karen A Blohm-Mangone; Jose L Padilla-Torres; Raymond B Nagle; Ignacio Moreno de Alboránç; Jose M Guillen-R; Eugene W Gerner
Journal:  Cancer Biol Ther       Date:  2006-12-07       Impact factor: 4.742

6.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

7.  Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.

Authors:  L K Su; K W Kinzler; B Vogelstein; A C Preisinger; A R Moser; C Luongo; K A Gould; W F Dove
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

8.  The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.

Authors:  Jose Sierra; Tomonori Yoshida; Claudio A Joazeiro; Katherine A Jones
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

9.  Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells.

Authors:  Gregory S Yochum; Shannon McWeeney; Veena Rajaraman; Ryan Cleland; Sandra Peters; Richard H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

10.  Myc deletion rescues Apc deficiency in the small intestine.

Authors:  Owen J Sansom; Valerie S Meniel; Vanesa Muncan; Toby J Phesse; Julie A Wilkins; Karen R Reed; J Keith Vass; Dimitris Athineos; Hans Clevers; Alan R Clarke
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

View more
  8 in total

1.  Regenerating Reputations: Are Wnt and Myc the Good Guys After All?

Authors:  Mark R Frey
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

Review 2.  Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer.

Authors:  Sherri Rennoll; Gregory Yochum
Journal:  World J Biol Chem       Date:  2015-11-26

3.  A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.

Authors:  Meera Shah; Sherri A Rennoll; Wesley M Raup-Konsavage; Gregory S Yochum
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Increased Musashi-2 and Decreased NUMB Protein Levels Observed in Human Colorectal Cancer are reverted to Normal Levels by ATRA-Induced Cell Differentiation.

Authors:  Lynn M Opdenaker; Ryan Kowash; Gabriel Masters; Bruce M Boman; Tao Zhang; Shirin R Modarai
Journal:  Int J Cancer Res Ther       Date:  2018-08-15

5.  A Role for MYC in Lithium-Stimulated Repair of the Colonic Epithelium After DSS-Induced Damage in Mice.

Authors:  Wesley M Raup-Konsavage; Timothy K Cooper; Gregory S Yochum
Journal:  Dig Dis Sci       Date:  2015-08-30       Impact factor: 3.199

6.  Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.

Authors:  Lijing Yao; Hui Shen; Peter W Laird; Peggy J Farnham; Benjamin P Berman
Journal:  Genome Biol       Date:  2015-05-21       Impact factor: 13.583

7.  The MYC 3' Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells.

Authors:  Sherri A Rennoll; Melanie A Eshelman; Wesley M Raup-Konsavage; Yuka Imamura Kawasawa; Gregory S Yochum
Journal:  Cancers (Basel)       Date:  2016-05-23       Impact factor: 6.639

8.  Tristetraprolin targets Nos2 expression in the colonic epithelium.

Authors:  Melanie A Eshelman; Stephen M Matthews; Emily M Schleicher; Rebecca M Fleeman; Yuka Imamura Kawasawa; Deborah J Stumpo; Perry J Blackshear; Walter A Koltun; Faoud T Ishmael; Gregory S Yochum
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.